Retour sur lavenir.net
   AGEAS 71.050 € (-0,91 %)     D'IETEREN GROUP 175.300 € (-0,51 %)     ARGENX SE 750.200 € (-0,05 %)     LOTUS BAKERIES 11 040.000 € (+0,36 %)     TUBIZE-FIN 207.600 € (+1,47 %)     SHURGARD 26.700 € (+0,56 %)     AB INBEV 70.720 € (+1,49 %)     DEME GROUP 171.800 € (-0,69 %)     WDP 22.020 € (+0,73 %)     WHAT'S COOKING GP 141.500 € (0,00 %)     VIOHALCO 17.720 € (-0,45 %)     HOME INVEST BE. 19.240 € (+0,94 %)     IBA 17.000 € (+1,80 %)     BPOST 1.588 € (-0,87 %)     TINC 11.260 € (+0,18 %)     GIMV 44.750 € (0,00 %)     MONTEA 67.400 € (+0,45 %)     ELIA GROUP 135.100 € (-2,60 %)     EXMAR 11.300 € (-1,31 %)     JENSEN-GROUP 86.000 € (+1,90 %)     RETAIL ESTATES 68.300 € (-0,58 %)     WERELDHAVE BELGIUM 53.400 € (-0,74 %)     PROXIMUS 6.130 € (+0,57 %)     AEDIFICA 69.850 € (+1,53 %)     ACCENTIS 0.027 € (0,00 %)     CAMPINE 211.000 € (0,00 %)     ORANGE BELGIUM 21.600 € (0,00 %)     ECONOCOM GROUP 1.470 € (-0,68 %)     UCB 237.700 € (+0,85 %)     ONTEX GROUP 2.340 € (+6,12 %)     NYXOAH 1.472 € (+3,66 %)     BELYSSE GROUP 0.460 € (-10,16 %)     UMICORE 19.270 € (-4,32 %)     DECEUNINCK 2.220 € (+0,23 %)     KBC 122.000 € (+1,04 %)     SOFINA 226.400 € (+0,18 %)     CFE 12.050 € (-2,43 %)     KBC ANCORA 85.600 € (+0,12 %)     AZELIS GROUP 10.980 € (+0,46 %)     TITAN S.A. 49.840 € (+0,28 %)     CARE PROPERTY INV. 12.740 € (+0,79 %)     CENERGY 20.560 € (+0,19 %)     CMB.TECH 13.800 € (+2,68 %)     CIE BOIS SAUVAGE 300.000 € (-1,64 %)     ONWARD MEDICAL 2.490 € (0,00 %)     GBL 77.800 € (-0,13 %)     ENERGYVISION 14.900 € (-0,27 %)     BREDERODE 103.800 € (+0,19 %)     ABO GROUP 3.900 € (0,00 %)     IMMOBEL 22.000 € (+1,85 %)     SYENSQO 68.450 € (-0,15 %)     VGP 80.600 € (-2,89 %)     COLRUYT 38.180 € (+1,06 %)     ASCENCIO 51.900 € (+0,19 %)     FLUXYS BELGIUM D 19.400 € (-3,00 %)     VAN DE VELDE 30.000 € (-0,33 %)     VASTNED 29.900 € (+0,34 %)     SOLVAY 26.180 € (-1,21 %)     BARCO 8.000 € (-1,90 %)     ACKERMANS V.HAAREN 271.000 € (-0,95 %)  
   MAGNUM 16.372 € (-0,26 %)     AIR LIQUIDE 177.080 € (+1,11 %)     CREDIT AGRICOLE 17.920 € (+0,84 %)     STELLANTIS NV 5.248 € (+1,45 %)     JCDECAUX 22.280 € (+4,50 %)     NOVACYT 0.460 € (+9,39 %)     STMICROELECTRONICS 55.990 € (-4,91 %)     CARVOLIX 5.600 € (-11,95 %)     HEINEKEN 76.640 € (+0,82 %)     TOTALENERGIES 69.590 € (-1,49 %)     VALERIO TX 0.597 € (+30,78 %)     IPSEN 157.900 € (-1,68 %)     ECOSLOPS 1.130 € (-5,04 %)     ASML HOLDING 1 598.400 € (+3,16 %)     VALEO 13.115 € (+3,06 %)     BNP PARIBAS ACT.A 102.940 € (+0,29 %)     BENETEAU 6.270 € (+1,13 %)     VERALLIA 20.320 € (0,00 %)     SOITEC 90.180 € (-7,64 %)     ATOS GROUP 31.280 € (-4,23 %)     VIVENDI SE 1.909 € (-0,73 %)     INVENTIVA 3.825 € (-1,16 %)     V LANSCHOT KEMPEN 68.350 € (-0,65 %)     TELEPERFORMANCE 54.340 € (-1,56 %)     KAUFMAN ET BROAD 25.900 € (0,00 %)     LEGRAND 137.700 € (-2,03 %)     SAFRAN 329.100 € (-0,51 %)     NN GROUP 78.000 € (-0,10 %)     KALRAY 7.800 € (-6,25 %)     CTP 16.220 € (-0,73 %)     TF1 6.840 € (+1,18 %)     DASSAULT AVIATION 278.800 € (-0,50 %)     TKH GROUP 43.860 € (+1,43 %)     RELX 29.560 € (0,00 %)     BOUYGUES 47.700 € (-1,16 %)     DSM FIRMENICH AG 86.540 € (+1,15 %)     PUBLICIS GROUPE SA 91.380 € (+3,07 %)     SCHNEIDER ELECTRIC 264.350 € (-2,15 %)     FONCIERE INEA 32.600 € (+0,31 %)     TIKEHAU CAPITAL 18.000 € (-0,99 %)     AHOLD DEL 35.920 € (+0,11 %)     SCOR SE 32.620 € (+1,43 %)     GENOWAY 2.610 € (+9,66 %)     PHILIPS KON 23.850 € (+0,42 %)     ADYEN 854.000 € (-2,06 %)     UNILEVER 54.560 € (+1,47 %)     FORVIA 9.282 € (-0,64 %)     WOLTERS KLUWER 62.700 € (-0,76 %)     TECHNIP ENERGIES 33.320 € (+0,48 %)     BAM GROEP KON 11.530 € (0,00 %)     CIBOX INTER A CTIV 0.012 € (-5,38 %)     COMPAGNIE ODET 1 396.000 € (-1,55 %)     APERAM 47.520 € (+1,15 %)     VINCI 120.200 € (+0,46 %)     VEOLIA ENVIRON. 37.220 € (-0,80 %)     REXEL 38.950 € (-0,59 %)     SAINT GOBAIN 76.620 € (-0,23 %)     AALBERTS NV 40.780 € (+0,94 %)     ESSILORLUXOTTICA 169.500 € (+0,77 %)     BAIKOWSKI 25.000 € (-0,79 %)  
News Réglementées
04/05/2023 15:00

Chi Botanic Inc. Awarded Competitive USDA SBIR Phase I Grant for Plant Cell-Cultured Vanilla

Small Business Innovative Research Program Provides $175,000 in Funding for Chi Botanic's Sustainable Vanilla Technology

ALAMEDA, CA / ACCESSWIRE / May 4, 2023 / ChiBotanic Inc. is pleased to announce that its research and commercialization project for a new cell-cultured Vanilla 2.0 technology for a plant-based full-spectrum natural vanilla flavor has been awarded a highly competitive Small Business Innovative Research (SBIR) Phase I Award of $175,000 from the United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA).

In vitro Vanilla
In vitro Vanilla



The proposal, "Vanilla 2.0: A reliable, sustainable, domestic supply of authentic Vanilla planifolia flavor and fragrance," will help support Chi Botanic's efforts to solve the many problems facing the natural vanilla supply chain, including a very difficult, laborious, slow-growing agricultural crop limited to tropical climates representing biodiversity hotspots. Political instability and extreme weather in regions where vanilla is grown further contribute to severe price fluctuations.

The technology Chi Botanic is creating will achieve a Vanilla planifolia plant cell culture that can be grown inexpensively anywhere and produce high concentrations of vanillin plus the many other flavor and fragrance metabolites of real vanilla. Major advantages to creation of a plant cell suspension culture specialized for production of the distinctive blend of vanilla phenylpropanoids are as follows:

  • Increased value of a complex, plant-based vanilla product over the inferior synthetic vanillin that makes up 99% of the vanilla flavor on the market today.
  • Unlike other synthetic biology-based methods, the system will provide the sustainability of fermentation-type methods, yet the end-product will be as complex as pure vanilla extract, which the FDA strictly defines as from vanilla seed pods. Thus, the Chi Botanic product will initially be labeled as "natural vanilla flavor" due to the source plant (Vanilla planifolia) from which the culture is derived, though not strictly from seed pods.
  • Economically viable, domestic production with tight control of quality and composition. Co-location with product manufacturing possible.
  • Faster growing, processing, and production times compared to farm-grown vanilla.
  • Over 18,000 products contain vanillin, yet less than 1% is sourced from the plant (Sethi, 2017). Chi Botanic's own market research with potential enterprise customers has proven an eagerness to assess and willingness to pay a premium for our proposed product, with one of the world's largest suppliers of vanilla quoted as "dreaming of the day" when this could be possible.

For more information, visit the corporate website at www.chibotanic.com or email info@chibotanic.com. Digital photos are available.

Contact Information
Jonathan (Jon) Meuser
Chief Executive Officer
jon@chibotanic.com
510-227-5237

SOURCE: Chi Botanic Inc.

.

View source version on accesswire.com:
https://www.accesswire.com/752904/Chi-Botanic-Inc-Awarded-Competitive-USDA-SBIR-Phase-I-Grant-for-Plant-Cell-Cultured-Vanilla

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière